May 7 |
Upgrade: Analysts Just Made A Massive Increase To Their Bicycle Therapeutics plc (NASDAQ:BCYC) Forecasts
|
May 6 |
Bicycle Therapeutics (BCYC) Moves to Buy: Rationale Behind the Upgrade
|
May 6 |
Wall Street Analysts See a 77.22% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High?
|
May 4 |
Bicycle Therapeutics First Quarter 2024 Earnings: Beats Expectations
|
May 2 |
Bicycle Therapeutics PLC (BCYC) Q1 2024 Earnings: Narrowing Losses Amidst Robust R&D Progress
|
May 2 |
Bicycle Therapeutics GAAP EPS of -$0.62 beats by $0.66, revenue of $19.53M beats by $13.5M
|
May 2 |
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
|
Apr 24 |
Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
|
Apr 2 |
Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 12 |
Bicycle: 2nd Half Of 2024 Data Could Provide Significant Inflection Point
|